Absence of immunostaining for growth hormone in a subset of patients with acromegaly

[1]  A. Vortmeyer,et al.  Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. , 2012, Journal of neurosurgery.

[2]  M. Grady,et al.  Clinically silent somatotroph adenomas are common , 2011, European journal of endocrinology.

[3]  P. Stewart,et al.  Mortality in patients with pituitary disease. , 2010, Endocrine reviews.

[4]  J. Vandenbroucke,et al.  Mortality in acromegaly: a metaanalysis. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  L. Niskanen,et al.  A nationwide survey of mortality in acromegaly. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  D. Rigamonti,et al.  Giant Somatotrophinoma without Acromegalic Features: More “Quiet” Than “Silent”: Case Report , 2005, Neurosurgery.

[7]  A. Barkan,et al.  Clinically silent somatotropinomas may be biochemically active. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  J. Ahlquist,et al.  A spectrum of behaviour in silent corticotroph pituitary adenomas , 2005, British journal of neurosurgery.

[9]  D. Figarella-Branger,et al.  The new WHO classification of human pituitary tumors: comments , 2005, Acta Neuropathologica.

[10]  T. Kameya,et al.  Significance of Growth Hormone-releasing Hormone Receptor mRNA in Non-neoplastic Pituitary and Pituitary Adenomas: A Study by RT-PCR and in situ Hybridization , 1999, Journal of Neuro-Oncology.

[11]  B. Claustrat,et al.  Morphological and biochemical relationships in 31 human pituitary adenomas with acromegaly , 2004, Virchows Archiv A.

[12]  H. Lüders,et al.  Comments , 2002, Clinical Neurophysiology.

[13]  H. Chiang,et al.  Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification , 2001, Histopathology.

[14]  R. McNally,et al.  Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study , 1998 .

[15]  S. Orme,et al.  Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. , 1998, The Journal of clinical endocrinology and metabolism.

[16]  P. Wrightson,et al.  Determinants of clinical outcome and survival in acromegaly , 1994, Clinical endocrinology.

[17]  W. Schlote,et al.  Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactin. , 1993, Clinical neuropathology.

[18]  T. Sano,et al.  Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. , 1993, The Journal of clinical endocrinology and metabolism.

[19]  G. Sassolas,et al.  Somatotropic adenomas without acromegaly. , 1991, Pathology, research and practice.

[20]  D. Lüdecke,et al.  In situ hybridization for different mRNA in GH-secreting and in inactive pituitary adenomas. , 1991, Pathology, research and practice.

[21]  S. Lamberts,et al.  GLYCOPROTEIN HORMONE ALPHA‐SUBUNIT AND PROLACTIN RELEASE BY CULTURED PITUITARY ADENOMA CELLS FROM ACROMEGALIC PATIENTS: CORRELATION WITH GH RELEASE , 1989, Clinical endocrinology.

[22]  K. Kovacs,et al.  Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. , 1989, The American journal of pathology.

[23]  S. Asa,et al.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. , 1989, The American journal of pathology.

[24]  B. Bengtsson,et al.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. , 2009, Acta medica Scandinavica.

[25]  K. Kovacs.  Pathology of growth hormone excess. , 1988, Pathology, research and practice.

[26]  K. Kovacs,et al.  Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. , 1987, Journal of Neurosurgery.

[27]  J. Klijn,et al.  Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. , 1980, Acta endocrinologica.

[28]  K. Kovacs,et al.  Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. , 1980, The American journal of pathology.